The influence of inhibiting or stimulating the expression of the α3 subunit of the nicotinic receptor in SH-SY5Y cells on levels of amyloid-β peptide and β-secretase

Neurochemistry International

Volumn 62, Issue 1, 2013, Pages 79-83

  Qi, Xiao Lan ^a   Zhang, Xue Ling ^a   Ou Yang, Kai ^a   Shan, Ke Ren ^a   Guan, Zhi Zhong ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

3 Nicotinic acetylcholine receptor; Amyloid peptide; Secretase; SH SY5Y cells

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE 1; BETA SECRETASE 2; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ACID ENDOPEPTIDASES; BLOTTING, WESTERN; CELL LINE, TUMOR; CULTURE MEDIA; HUMANS; NICOTINE; NICOTINIC AGONISTS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, NICOTINIC; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84870988563     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.11.012     Document Type: Article

References (41)

1. E. Albuquerque, M. Alkondon, E.F. Pereira, N.G. Castro, A. Schrattenholz, C.T. Barbosa, R. Bonfante-Cabarcas, Y. Aracava, H.M. Eisenberg, and A. Maelicke Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function J. Pharmacol. Exp. Ther. 280 1997 1117 1136
2. R. Boyd, M.H. Thomas, A.E. Jacob, S. Couturier, M. Ballivet, and D.K. Berg Expression and regulation of neuronal acetylcholine receptor mRNA in chick ciliary ganglia Neuron 1 1988 495 502
3. R. Boyd, M.H. Thomas, A.E. Jacob, S.C. McEachern, and D.K. Berg Nicotinic acetylcholine receptor mRNA in dorsal root ganglion neurons J. Neurobiol. 22 1991 1 14
4. H. Braak, and K. Del Tredici Alzheimer's pathogenesis: is there neuron-to-neuron propagation? Acta Neuropathol. 121 2011 589 595
5. A. Campos-Caro, F.I. Smillie, E. Dominguez del Toro, J.C. Rovira, F. Vincente-Agullo, J. Chapuli, J.M. Juiz, S. Sala, F. Sala, J.J. Ballesta, and M. Criado Neuronal nicotinic acetylcholine receptors on bovine chromaffin cells: cloning, expression, and genomic organization of receptor subunits J. Neurochem. 68 1997 488 497
6. P.B. Clarke, and M. Reuben Release of [3H]-noradrenaline from hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release Br. J. Pharmacol. 117 1996 595 606
7. S.L. Cole, and R. Vassar The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology J. Biol. Chem. 283 2008 29621 29625
8. --nicotinic acetylcholine receptor availability after chronic ethanol exposure in nonhuman primates Synapse 29 2010 729 732
9. S. Couturier, L. Erkman, S. Valera, D. Rungger, S. Bertrand, J. Boulter, M. Ballivet, and D. Bertrand 5,3, and non-3: three clustered avian genes encoding neuronal nicotinic acetylcholine receptor-related subunits J. Biol. Chem. 265 1990 17560 17567
10. S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 2001 494 498
11. A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 1998 806 811
12. G. Gevorkian, A. Gonzalez-Noriega, G. Acero, J. Ordoñez, C. Michalak, M.E. Munguia, T. Govezensky, D.H. Cribbs, and K. Manoutcharian Amyloid-beta peptide binds to microtubule-associated protein 1B (MAP1B) Neurochem. Int. 52 2008 1030 1036
13. J. Götz, L.M. Ittner, N. Schonrock, and R. Cappai An update on the toxicity of Aβ in Alzheimer's disease Neuropsychiatr. Dis. Treat. 4 2008 1033 1042
14. Z.Z. Guan, X. Zhang, R. Ravid, and A. Nordberg Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease J. Neurochem. 74 2000 237 243
15. Z.Z. Guan, H. Miao, J.Y. Tian, C. Unger, A. Nordberg, and X. Zhang Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells J. Neural. Transm. 108 2001 1417 1433
16. E. Hamel, N. Nicolakakis, T. Aboulkassim, B. Ongali, and X.K. Tong Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease Exp. Physiol. 93 2008 116 120
17. G.J. Hannon, and J.J. Rossi Unlocking the potential of the human genome with RNA interference Nature 431 2004 371 378
18. L. Ke, C.M. Elisenhour, M. Bencherif, and R.J. Lukas Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment J. Pharmacol. Exp. Ther. 286 1998 825 840
19. T. Kihara, S. Shimohama, H. Sawada, J. Kimura, T. Kume, H. Kochiyama, T. Maeda, and A. Akaike Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity Ann. Neurol. 42 1997 159 163
20. J.M. Kulak, T.A. Nguyen, B.M. Olivera, and J.M. McIntosh A-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes J. Neurosci. 17 1997 5263 5270
21. E. Lomazzo, L. MacArthur, R.P. Yasuda, B.B. Wolfe, and K.J. Kellar Quantitative analysis of the heteromeric neuronal nicotinic receptors in the rat hippocampus J. Neurochem. 3 2010 625 634
22. M. Mousavi, E. Hellström-Lindahl, Z.Z. Guan, K.R. Shan, R. Ravid, and A. Nordberg Protein and mRNA levels of nicotinic receptors in brain of tobacco-using controls and patients with Alzheimer's disease Neuroscience 122 2003 515 520
23. M. Nassif, J. Hoppe, K. Santin, R. Frozza, L.L. Zamin, F. Simao, A.P. Horn, and C. Salbego Beta-amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK-3beta, and PTEN Neurochem. Int. 50 2007 229 235
24. A. Nordberg Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications Biol. Psychiatry 49 2001 200 210
25. A. Nordberg, E. Hellström-Lindahl, M. Lee, M. Johnson, M. Mousavi, R. Hall, E. Perry, I. Bednar, and J. Court Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw) J. Neurochem. 81 2002 655 658
26. M.J. O'Neill, T.K. Murray, V. Lakics, N.P. Visanji, and S. Duty The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration Curr. Drug Targets CNS Neurol. Disord. 1 2002 399 411
27. D. Paterson, and A. Nordberg Neuronal nicotinic receptors in the human brain Prog. Neurobiol. 61 2000 75 111
28. X. Peng, V. Gerzanich, R. Anand, F. Wang, and J. Lindstrom Chronic nicotine treatment up-regulates α3 and α7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y Mol. Pharmacol. 51 1997 776 784
29. K. Poth, T.J. Nutter, J. Cuevas, M.J. Parker, D.J. Adams, and C.W. Luetje Heterogeneity of nicotinic receptor class and subunit mRNA expression among individual parasympathetic neurons from rat intracardiac ganglia J. Neurosci. 17 1997 586 596
30. X.L. Qi, A. Nordberg, J. Xiu, and Z.Z. Guan The consequences of reducing expression of the 7 nicotinic receptor by RNA interference and of stimulating its activity with an 7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease Neurochem. Int. 51 2007 377 383
31. A.P. Raval, A. Bhatt, and I. Saul Chronic nicotine exposure inhibits 17 beta-estradiol-mediated protection of the hippocampal CA1 region against cerebral ischemia in female rats Neurosci. Lett. 2 2009 65 69
32. J. Roensch, M. Crisby, A. Nordberg, Y. Xiao, L.J. Zhang, and Z.Z. Guan Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amyloid precursor peptide in SH-SY5Y cells Neurochem. Int. 50 2007 800 806
33. A.O. Rosa, J. Egea, L. Gandía, M.G. López, and A.G. García Neuroprotection by nicotine in hippocampal slices subjected to oxygen-glucose deprivation: involvement of the alpha7 nAChR subtype J. Mol. Neurosci. 30 2006 61 62
34. M. Sakono, and T. Zako Amyloid oligomers: formation and toxicity of Aβ oligomers FEBS J. 277 2010 1348 1358
35. D.J. Selkoe Clearing the brain's amyloid cobwebs Neuron 32 2001 177 180
36. T. Shimizu, K. Tanaka, T. Hasegawa, and K. Yokotani Brain α4β2 nicotinic acetylcholine receptors are involved in the secretion of noradrenaline and adrenaline from adrenal medulla in rats Eur. J. Pharmacol. 3 2011 241 248
37. Z. Tang, Y. An, X.L. Qi, Y. Xiao, K.R. Shan, and Z.Z. Guan Inhibiting gene expression of alpha3 nicotinic receptor in SHSY5Y cells with the effects on APP metabolism and antioxidation in Alzheimer's disease Neurochem. Int. 53 2008 112 117
38. M. Tijsterman, R.F. Ketting, and R.H. Plasterk The genetics of RNA silencing Ann. Rev. Genet. 36 2002 489 519
39. J. Xiu, A. Nordberg, X.L. Qi, and Z.Z. Guan Influence of cholesterol and lovastatin on alpha-form of secreted amyloid precursor protein and expression of alpha7 nicotinic receptor on astrocytes Neurochem. Int. 49 2006 459 465 [13]
40. A.B. Vernallis, W.G. Conroy, and D.K. Berg Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes Neuron 10 1993 451 464
41. H. Zeng, Y. Zhang, L. Peng, H. Shao, N.K. Menon, J. Yang, A.R. Salomon, R.P. Freidland, and M.G. Zagorski Nicotine and amyloid formation Biol. Psychiatry 49 2001 248 257